Secondary measures assessed efficacy, safety & tolerability endpoints using the PANSS, BPRS Psychosis score, CGI-S, CGI-GI, Calgary Depression Scale for Schizophrenia, Brief Assessment of Cognition for Schizophrenia, and others.
18 Years to 65 Years (Adult)
November 18, 2002
August 16, 2017
GSK Clinical Trial Call Center Scottsdale, Arizona, United States
GSK Clinical Trial Call Center Cerritos, California, United States
GSK Clinical Trial Call Center Chula Vista, California, United States
(and 28 more...)
† Study has passed its completion date and status has not been verified in more than two years.